Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ASP3026 |
Trade Name | |
Synonyms | ASP-3026|ASP 3026 |
Drug Descriptions |
ASP3026 inhibits ALK, with activity against ALK fusions and mutations, and ROS1, potentially resulting in decreased viability of tumor cells and reduced tumor growth (PMID: 24419060, PMID: 29491259, PMID: 26964870, PMID: 31177400). |
DrugClasses | ALK Inhibitor 33 ROS1 Inhibitor 22 |
CAS Registry Number | 1097917-15-1 |
NCIT ID | C116727 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ASP3026 | ASP3026 | 16 | 0 |